Effects of chondroitin sulfates on serum lipids and hexosamines in atherosclerotic patients: with special reference to thrombus formation time.
D000328:Adult; D000368:Aged; D000606:Amino Sugars / Q000097:blood; D001161:Arteriosclerosis / Q000097:blood* / Q000188:drug therapy; D001780:Blood Coagulation Tests; D002784:Cholesterol / Q000097:blood; D002807:Chondroitin / Q000627:therapeutic use*; D005260:Female; D005690:Galactose; D006595:Hexosamines / Q000097:blood*; D006801:Humans; D007275:Injections, Intravenous; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood; D013431:Sulfates; D013927:Thrombosis; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D000606:Amino Sugars; D006595:Hexosamines; D008055:Lipids; D010743:Phospholipids; D013431:Sulfates; D014280:Triglycerides; D002807:Chondroitin; D002784:Cholesterol; D005690:Galactose